Literature DB >> 9848819

Gastroesophageal reflux disease.

P O Katz1.   

Abstract

Gastroesophageal reflux disease (GERD) is a spectrum of disease that can best be defined as the symptoms and/or signs of esophageal or adjacent organ injury secondary to the reflux of gastric contents into the esophagus or, beyond, into the oral cavity or airways. Injury is defined based on symptoms or organ damage resulting in esophagitis, laryngeal inflammation, or acute and/or chronic pulmonary injury. Though specific studies are lacking, GERD seems to occur more frequently in older people. In general, because it has been present for a longer period of time, older patients will often present with more complicated GERD, including severe erosive esophagitis, peptic stricture, and Barrett's esophagus, a premalignant condition, making treatment of older patients with GERD potentially more difficult and complex. Though it is not usually life-threatening, GERD can have a major effect on patients' well-being and quality of life. This article reviews the presentation, pathophysiology, diagnosis, and treatment of GERD as it relates to the older patient.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9848819     DOI: 10.1111/j.1532-5415.1998.tb01543.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  7 in total

1.  Life threatening vitamin B(12) deficiency: will timely screening make a difference.

Authors:  T S Dharmarajan; S Lakshmi Narayanan; Rajiv D Poduval
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Effect of food on the pharmacokinetics of YH4808, a potassium-competitive acid blocker, after single- and multiple-oral dosing in healthy subjects.

Authors:  Eunwoo Kim; Anhye Kim; Sojeong Yi; Yu Kyong Kim; Seong Bok Jang; Hae Mi Byun; Seo Hyun Yoon; Joo-Youn Cho; In-Jin Jang; Kyung-Sang Yu; SeungHwan Lee
Journal:  Eur J Clin Pharmacol       Date:  2018-06-15       Impact factor: 2.953

3.  Does CPAP treatment lead to gastroesophageal reflux in patients with moderate and severe OSA?

Authors:  Hatice Ozcelik; Yusuf Kayar; Ahmet Danalioglu; Elif Arabaci; Omer Uysal; Fatih Yakar; Levent Kart
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-22       Impact factor: 2.503

4.  Effectiveness of salivary stimulation using xylitol-malic acid tablets as coadjuvant treatment in patients with gastro-oesophageal reflux disease: early findings.

Authors:  I Sánchez-Blanco; M Rodríguez-Téllez; J-R Corcuera-Flores; C González-Blanco; D Torres-Lagares; M-Á Serrera-Figallo; G Machuca-Portillo
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-11-01

5.  Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease.

Authors:  Roger Jones; Silke Horbach; Peter Sander; Tina Rydén-Bergsten
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

6.  Variables affecting the occurrence of gastroesophageal reflux in obstructive sleep apnea patients.

Authors:  Ozcan Oztürk; Levent Oztürk; Ahmet Ozdogan; Fatih Oktem; Zerrin Pelin
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-08-12       Impact factor: 2.503

7.  Outcomes of minimally invasive antireflux operations in the elderly: a comparative review.

Authors:  Hiran C Fernando; Philip R Schauer; Percival O Buenaventura; Neil A Christie; John M Close; James D Luketich
Journal:  JSLS       Date:  2003 Oct-Dec       Impact factor: 2.172

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.